Practice of Pleural Drainage in a Pediatric Hospital Over a Three-Year Period in Abidjan, Ivory Coast

Gro Bi AM^1,2*, Mansou A^1,2*, Djivohessoun A^1,2, Djoman I^1,2, Aké-Assi MH^1,2, Dainguy ME^1,2, Kouadio E^1,2, Kouakou C^1,2, N'gatta P², Sorho C² and Folquet A^1,2

¹Félix Houphouët Boigny University 01 BPV 34 Abidjan 01, Abidjan, Ivory Coast
²Pediatrics Department, Cocody University Hospital, Abidjan BP 22 V13, Ivory Coast

*Corresponding Author: Gro Bi AM, Félix Houphouët Boigny University 01 BPV 34 Abidjan 01, Abidjan, Ivory Coast.

Received: September 22, 2025; Published: November 13, 2025

Abstract

Introduction: Complications associated with pleural drainage are the cause of significant morbidity and mortality. The objective of this study was to describe our experience in the practice of pleural drainage in a pediatric hospital setting.

Methodology: This was a retrospective, analytical cross-sectional study. We identified the pleuropulmonary conditions for which drainage was performed in the medical pediatrics department of the Cocody University Hospital from January 1, 2020 to December 31, 2022. The Chi 2 test was used to study the statistical significance at an error threshold of 5%.

Results: We collected 120 cases of thoracic drainage. The mean age of the patients was 47.66 months. The mean hospital stay was 10.42 days. The main morbid conditions were purulent pleurisy (61.7%), hydropneumothorax (31.7%) and spontaneous pneumothorax (6.7%). The mean time for drain placement was 3.16 days with extremes of 0 and 8 days. The drain site was axillary in all children and the technique used was the mandrel technique with the Joly drain whose size varied according to the patient's age. Complications occurred in 51 patients (42.5%). In 20.8% of cases, transfer to a specialized thoracic surgery department was necessary. The factors associated with this transfer were severe acute malnutrition (p = 0.008) and the long duration of evolution of the signs before drainage (p = 0.017).

Conclusion: The pleural drainage efficiency goes through the early conditions’ diagnosis requiring the drain placement and the know-how in this therapeutic procedure.

Keywords: Child; Lungs; Drain; Ivory Coast

References

1. “2022 Alzheimer’s disease facts and figures”. Alzheimer’s and Dementia 4 (2022): 700-789.
2. Liz Yuanxi Lee., et al. "Robust and interpretable AI-guided marker for early dementia prediction in real-world clinical settings”. EClinicalMedicine 102725 (2024): 102725-102725.
3. Ali R., et al. "A self-training deep neural network for early prediction of cognitive deficits in very preterm infants using brain functional connectome data”. Pediatric Radiology 11 (2022): 2227-2240.
4. Pahar M., et al. "CognoSpeak: an Automatic, Remote Assessment of Early Cognitive Decline in Real-World Conversational Speech”. In (2025): 1-7.
5. Fristed E., et al. "A remote speechbased AI system to screen for early Alzheimer’s disease via smartphones”. Alzheimer’s and Dementia1 (2022): e12366.
6. Quek LJ., et al. "Use of artificial intelligence techniques for detection of mild cognitive impairment: A systematic scoping review. Journal of Clinical Nursing17-18 (2023): 5752-5762.
7. Chu C., et al. "Development and Validation of a Tool to Predict Onset of Mild Cognitive Impairment and Alzheimer Dementia”. JAMA Network Open1 (2025): e2453756.
8. Rasmussen J and Langerman H. “Alzheimer’s Disease – Why We Need Early Diagnosis”. Degenerative Neurological and Neuromuscular Disease 9 (2019): 123-130.
9. Rosenberg PB and Lkyetsos C. “Mild Cognitive impairment: Searching for the Prodrome of Alzheimer’s Disease”. World Psychiatry 2 (2008): 72-78.
10. Petersen RC. “Mild Cognitive Impairment. CONTINUUM: Lifelong Learning in Neurology 2 (2016): 404-418.
11. S. Census Bureau. “Population Estimates Program”. PEP Vintage 2019 Population and Housing Unit Estimates. Published online (2019).
12. Alzheimer's Association. “2025 Alzheimer’s Disease Facts and Figures”. Alzheimer’s and Dementia4 (2021).
13. Lin CC., et al. "Geographic Variation in Neurologist Density and Neurologic Care in the United States”. Neurology3 (2020): e309-e321.
14. Reiter-Campeau S and Moore F. “The Role of the Neurological Examination in Primary Care Referrals to Neurology”. The Canadian Journal of Neurological sciences Le Journal Canadien Des Sciences Neurologiques 6 (2022): 922-924.
15. Prince M., et al. "World Alzheimer Report 2011”. Alzheimer’s Disease International (ADI) (2011).
16. Rao A and Eaton R. “Dementia Neurology Deserts and Long-Term Care Insurance Claims Experience in the United States: How Does Limited Supply of Neurology Specialists Correlate with Claims Experience Data?” Society of Actuaries (2021).
17. Beyer L., et al. "Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer’s disease diagnosis within 17 years”. Alzheimer’s and Dementia3 (2022): 1020-1028.
18. Francisco de A., et al. "Automatic detection of cognitive impairment in elderly people using an entertainment chatbot with Natural Language Processing capabilities”. Journal of Ambient Intelligence and Humanized Computing 12 (2023): 16283-16298.
19. Haghayegh Shahab., et al. "Predicting future risk of developing cognitive impairment using ambulatory sleep EEG: Integrating univariate analysis and multivariate information theory approach”. Journal of Alzheimer’s Disease (2025):
20. Li H and Fan Y. “Early prediction of Alzheimer’s disease dementia based on baseline Hippocampal MRI and 1-Year Follow-Up Cognitive Measures Using Deep Recurrent Neural Networks”. 2019 IEEE 16th International Symposium on Biomedical Imaging ISBI 2019). (2019): 368-371.
21. Benedict RH., et al. "Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis”. Multiple Sclerosis Journal5 (1997): 721-733.
22. MacLeod CM. “Half a century of research on the Stroop effect: An integrative review”. Psychological Bulletin2 (1991): 163-203.
23. Hall JB., et al. "Feasibility of Using a Novel, Multimodal Motor Function Assessment Platform with Machine Learning to Identify Individuals with Mild Cognitive Impairment”. Alzheimer Disease and Associated Disorders 4 (2024): 344-350.
24. Civitarese G., et al. "The SERENADE Project: SensorBased Explainable Detection of Cognitive Decline”. (2025).
25. Liew TM., et al. "PENSIEVE-AI a brief cognitive test to detect cognitive impairment across diverse literacy”. Nature Communications 1 (2025).
26. Shakespeare R., et al. "Retinal vasculometry associations with cognition status in UK Biobank”. Alzheimer’s and Dementia1 (2025): e270087.
27. Nasreddine Ziad S., et al. "The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment”. Journal of the American Geriatrics Society 4 (2025): 695-699.
28. Sperling RA., et al. "Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease”. Alzheimer’s and Dementia3 (2011): 280-292.
29. Filardi M., et al. "The Relationship Between Muscle Strength and Cognitive Performance Across Alzheimer’s Disease Clinical Continuum”. Frontiers in Neurology 13 (2022):
30. Camicioli R., et al. "Motor slowing precedes cognitive impairment in the oldest old”. Neurology 5 (1998): 1496-1498.
31. Hebert LE., et al. "Upper and Lower Extremity Motor Performance and Functional Impairment in Alzheimer’s Disease”. American Journal of Alzheimer’s Disease and Other Dementiasry 5 (2025): 425-431.
32. Panwar D., et al. "Role of Artificial Intelligence in Cognitive Assessment and Early Detection of Alzheimer’s Disease”. In (2024): 190-210.
33. Insel TR. “Digital Phenotyping: Technology for a New Science of Behavior”. JAMA 13 (2017): 1215-1216.
34. Babulal Ganesh M., et al. "Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: Update and areas of immediate need”. Alzheimer’s and Dementia2 (2019): 292-312.
35. Ghosh S. “Alzheimer’s Therapeutics Market Share Analysis”. Future Market Insights (2025).
36. Torous J., et al. "New Tools for New Research in Psychiatry: A Scalable and Customizable Platform to Empower Data Driven Smartphone Research. JMIR Mental Health 2 (2016): e16.
37. Cummings J., et al. "Alzheimer’s disease drug development pipeline: 2021”. Alzheimer’s and Dementia1 (2021): e12179.
38. Lee LY., et al. "Robust and interpretable AIguided marker for early dementia prediction in realworld clinical settings”. eClinicalMedicine 74 (2024).
39. Wang D and Agapito G. “Editorial: Multi-omics approaches in the study of human disease mechanisms”. Frontiers in Bioinformatics 4 (2025).

Citation

Citation: Gro Bi AM., et al. “Practice of Pleural Drainage in a Pediatric Hospital Over a Three-Year Period in Abidjan, Ivory Coast". Acta Scientific Paediatrics 8.12 (2025): 03-10.

Copyright

Copyright: © 2025 Gro Bi AM., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.